These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2054699)

  • 21. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
    Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T
    Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [What is guaranteed in the therapy of hepatic encephalopathy?].
    Plauth M; Egberts EH
    Internist (Berl); 1993 Jan; 34(1):35-42. PubMed ID: 8440573
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy.
    Jones EA; Skolnick P
    Prog Liver Dis; 1990; 9():345-70. PubMed ID: 2156301
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of benzodiazepine in hepatic encephalopathy.
    Mullen KD
    Hepatology; 1995 Feb; 21(2):604-5. PubMed ID: 7843738
    [No Abstract]   [Full Text] [Related]  

  • 25. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The visual evoked potential in clinical hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Bolton RP; Losowsky MS
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():66-73. PubMed ID: 2083938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G; Ferenci P; Katzenschlager R; Madl C; Schneeweiss B; Laggner AN; Lenz K; Gangl A
    Lancet; 1988 Dec; 2(8625):1392-4. PubMed ID: 2904525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
    Romero Gómez M; Bautista JD; Grande L; Ramos Guerrero RM; Sánchez Muñoz D
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():40-8. PubMed ID: 15195533
    [No Abstract]   [Full Text] [Related]  

  • 31. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
    Gyr K; Meier R
    Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GABA-benzodiazepine receptor complex: therapeutic role of benzodiazepine antagonists].
    Andresen M; Arrese M; Dougnac A; Godoy J; Prat G; Chianale J
    Rev Med Chil; 1989 Aug; 117(8):944-6. PubMed ID: 2562414
    [No Abstract]   [Full Text] [Related]  

  • 35. Flumazenil: potential implications for hepatic encephalopathy.
    Jones EA; Basile AS; Mullen KD; Gammal SH
    Pharmacol Ther; 1990; 45(3):331-43. PubMed ID: 2105510
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of hepatic encephalopathy with flumazenil].
    Marsepoil T; Hermant JL; Ho P; Blin F; Levesque P
    Ann Fr Anesth Reanim; 1990; 9(4):399-400. PubMed ID: 2119158
    [No Abstract]   [Full Text] [Related]  

  • 37. Flumazenil and hepatic encephalopathy.
    Amaral OB; Quevedo J; Walz R; Kapczinski F
    Hepatology; 1999 Apr; 29(4):1338-9. PubMed ID: 10336339
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flumazenil and hepatic encephalopathy.
    Klotz U; Walker S
    Lancet; 1989 Jan; 1(8630):155-6. PubMed ID: 2563065
    [No Abstract]   [Full Text] [Related]  

  • 40. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.